IL103499A0 - Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients - Google Patents

Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients

Info

Publication number
IL103499A0
IL103499A0 IL103499A IL10349992A IL103499A0 IL 103499 A0 IL103499 A0 IL 103499A0 IL 103499 A IL103499 A IL 103499A IL 10349992 A IL10349992 A IL 10349992A IL 103499 A0 IL103499 A0 IL 103499A0
Authority
IL
Israel
Prior art keywords
benzodiazepine
pharmaceutical compositions
treating anxiety
withdrawn
patients
Prior art date
Application number
IL103499A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL103499A0 publication Critical patent/IL103499A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL103499A 1991-10-24 1992-10-21 Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients IL103499A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78201091A 1991-10-24 1991-10-24

Publications (1)

Publication Number Publication Date
IL103499A0 true IL103499A0 (en) 1993-03-15

Family

ID=25124656

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103499A IL103499A0 (en) 1991-10-24 1992-10-21 Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients

Country Status (18)

Country Link
US (1) US5278164A (fr)
EP (1) EP0538897B1 (fr)
JP (1) JPH05238934A (fr)
KR (1) KR100196334B1 (fr)
AT (1) ATE150645T1 (fr)
AU (1) AU649169B2 (fr)
CA (1) CA2081062A1 (fr)
CY (1) CY2019A (fr)
DE (1) DE69218544T2 (fr)
DK (1) DK0538897T3 (fr)
ES (1) ES2101000T3 (fr)
GR (1) GR3022945T3 (fr)
HK (1) HK113897A (fr)
IL (1) IL103499A0 (fr)
OA (1) OA09766A (fr)
PH (1) PH30028A (fr)
TW (1) TW217382B (fr)
ZA (1) ZA928105B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091418A1 (fr) * 2010-01-25 2011-07-28 Northeastern University Procédé de criblage d'effets secondaires indésirables d'un médicament pharmaceutique thérapeutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain

Also Published As

Publication number Publication date
AU2716592A (en) 1993-04-29
EP0538897B1 (fr) 1997-03-26
DE69218544T2 (de) 1997-11-13
TW217382B (fr) 1993-12-11
OA09766A (en) 1993-11-30
HK113897A (en) 1997-08-29
CY2019A (en) 1998-02-20
DK0538897T3 (da) 1997-08-25
ES2101000T3 (es) 1997-07-01
AU649169B2 (en) 1994-05-12
ATE150645T1 (de) 1997-04-15
KR930007452A (ko) 1993-05-20
ZA928105B (en) 1993-08-25
GR3022945T3 (en) 1997-06-30
PH30028A (en) 1996-11-08
KR100196334B1 (ko) 1999-06-15
EP0538897A1 (fr) 1993-04-28
DE69218544D1 (de) 1997-04-30
JPH05238934A (ja) 1993-09-17
US5278164A (en) 1994-01-11
CA2081062A1 (fr) 1993-04-25

Similar Documents

Publication Publication Date Title
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
DE69230112T2 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
BG101118A (en) Therapeutical compounds
ZA956029B (en) Combination treatment for inhibiting bone loss
HK1006421A1 (en) Levobupivacaine useful for managing chronic pain
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
NZ320355A (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
GR3032041T3 (en) Idebenone compositions for treating Alzheimer's disease.
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
IL118833A (en) Sertraline for use as a medicament in the treatment of post-myocardial infarction patients
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
FI953514A0 (fi) Uusi osteoblastien proliferaatiotekijä
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
UA28288A (uk) Спосіб лікування шизофренії
UA12417A (uk) Спосіб лікуваhhя виразкової хвороби дваhадцятипалої кишки